Clostridioides Difficile Infection: Analyzing CLInic Evolution and Bacterial Clearance

Abroad (travel likely)Recruiting

Conditions

Clostridium Difficile Infections

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fondation Hôpital Saint-Joseph, Paris, France
Contact: Study coordinator (Assaf MIZRAHI, MD)

Study leads

Assaf MIZRAHI, MD
Principal Investigator
Fondation Hôpital Saint-Joseph

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach

Clostridium Difficile · Ulcerative Colitis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Rome, Italy

Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile

Clostridium Difficile Infection Recurrence · Clostridium Difficile Infection

Abroad (travel likely)Recruiting

Worcester, United States

Fecal Microbiota Transplant National Registry

Fecal Microbiota Transplantation · Clostridium Difficile Infection · Gut Microbiome

Abroad (travel likely)Recruiting

Phoenix, United States · Los Angeles, United States

Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients

Clostridium Difficile Infection · Vancomycin Resistant Enterococci Infection

Abroad (travel likely)RecruitingPHASE2, PHASE3

Moreno Valley, United States